Clinical Trial Update: Optimization of Synvisc-One for Knee OA [NA]

View source ↗

Summary

A terminated clinical trial evaluating optimization of Synvisc-One for knee osteoarthritis. Results were posted in April 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Synvisc-One (hylan G-F 20)

Snippet

Sponsor: Elaine Husni | Conditions: Knee Osteoarthritis | NA | Status: TERMINATED | Results posted: 2017-04-21